These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8901825)

  • 1. Left ventricular hypertrophy and QT dispersion in hypertension.
    Mayet J; Shahi M; McGrath K; Poulter NR; Sever PS; Foale RA; Thom SA
    Hypertension; 1996 Nov; 28(5):791-6. PubMed ID: 8901825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dispersion of the QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy.
    Perkiömäki JS; Ikäheimo MJ; Pikkujämsä SM; Rantala A; Lilja M; Kesäniemi YA; Huikuri HV
    Hypertension; 1996 Jul; 28(1):16-21. PubMed ID: 8675257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA).
    Malmqvist K; Kahan T; Edner M; Bergfeldt L
    Am J Cardiol; 2002 Nov; 90(10):1107-12. PubMed ID: 12423712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
    Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
    Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy.
    Mayet J; Ariff B; Wasan B; Chapman N; Shahi M; Poulter NR; Sever PS; Foale RA; Thom SA
    Hypertension; 2000 Nov; 36(5):755-9. PubMed ID: 11082139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.
    Oikarinen L; Nieminen MS; Toivonen L; Viitasalo M; Wachtell K; Papademetriou V; Jern S; Dahlöf B; Devereux RB; Okin PM;
    Am Heart J; 2003 May; 145(5):919-25. PubMed ID: 12766755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy.
    Galetta F; Franzoni F; Magagna A; Femia FR; Pentimone F; Santoro G; Carpi A
    Biomed Pharmacother; 2005; 59(1-2):15-9. PubMed ID: 15740930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients.
    Nielsen FS; Sato A; Ali S; Tarnow L; Smidt UM; Kastrup J; Parving HH
    Diabetes Care; 1998 May; 21(5):804-9. PubMed ID: 9589245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril.
    González-Juanatey JR; García-Acuña JM; Pose A; Varela A; Calvo C; Cabezas-Cerrato J; de la Peña MG
    Am J Cardiol; 1998 Jan; 81(2):170-4. PubMed ID: 9591900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QT dispersion and hypertensive heart disease in the elderly.
    Gryglewska B; Grodzicki T; Czarnecka D; Kawecka-Jaszcz K; Kocemba J
    J Hypertens; 2000 Apr; 18(4):461-4. PubMed ID: 10779098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of chronic oral antihypertensive therapies on systemic arterial circulation and ventricular energetics in African-American patients.
    Cholley BP; Shroff SG; Sandelski J; Korcarz C; Balasia BA; Jain S; Berger DS; Murphy MB; Marcus RH; Lang RM
    Circulation; 1995 Feb; 91(4):1052-62. PubMed ID: 7850941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between nebivolol and ramipril in patients with hypertension and left ventricular hypertrophy: a randomized open blinded end-point (PROBE) trial.
    Cağlar N; Dincer I
    Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1359-68. PubMed ID: 22288296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT dispersion and left ventricular hypertrophy in elderly hypertensive and normotensive patients.
    Dimopoulos S; Nicosia F; Donati P; Prometti P; De Vecchi M; Zulli R; Grassi V
    Angiology; 2008; 59(5):605-12. PubMed ID: 18388029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QT dispersion in essential hypertension.
    Clarkson PB; Naas AA; McMahon A; MacLeod C; Struthers AD; MacDonald TM
    QJM; 1995 May; 88(5):327-32. PubMed ID: 7796087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between stage of left ventricular diastolic dysfunction and QT dispersion.
    Gunduz H; Akdemir R; Binak E; Tamer A; Uyan C
    Acta Cardiol; 2003 Aug; 58(4):303-8. PubMed ID: 12948035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass.
    Myers MG; Leenen FH; Tanner J
    Am J Hypertens; 1995 Jul; 8(7):712-8. PubMed ID: 7546497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of left ventricular hypertrophy by ACE-inhibitor, ramipril in comparison with calcium-channel antagonist, felodipine.
    Cacciapuoti F; Capasso A; Mirra G; De Nicola A; Minicucci F; Gentile S
    Int J Cardiol; 1998 Jan; 63(2):175-8. PubMed ID: 9510492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [QT dispersion and characteristics of left ventricular hypertrophy in primary hypertension].
    Szymański L; Mandecki T; Twardowski R; Mizia-Stec K; Szulc A; Jastrzebska-Maj E
    Pol Arch Med Wewn; 2002 Jan; 107(1):19-27. PubMed ID: 12046340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term improvement of QT dispersion is unaffected by short-term changes in blood pressure during treatment of systemic hypertension with enalapril.
    Seara FJ; Juanatey JR; Sande JL; Veloso PR; Reino AP; Román AV; Cerrato JC; Peña MG
    Ann Noninvasive Electrocardiol; 2003 Jan; 8(1):47-54. PubMed ID: 12848813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [QT dispersion intervals in hypertensives with left ventricular hypertrophy].
    Ghanem Wisam MA; Murín J; Jaber J; Radman A; Bulas J; Kozliková K
    Vnitr Lek; 2001 Jan; 47(1):20-4. PubMed ID: 15635864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.